-
BioGeneration Ventures Fund III reaches EUR 82 million in final close
October 31, 2017BioGeneration Ventures Fund III reaches EUR 82 million in final close Investments from Bristol-Myers Squibb and Johnson & Johnson...
0 -
BioGeneration Ventures Fund III Secures EUR 66m, exceed EUR 50m target
June 27, 2017Naarden, The Netherlands, 27 June 2017 – BioGeneration Ventures (BGV), the early stage Life Sciences Venture Capital firm with...
